Document is current

Any future updates will be listed below

AMG-232, a New Inhibitor of MDM-2,Enhance Doxorubicin Efficiency in Pre-B Acute Lymphoblastic Leukemia Cells

Crossref DOI link: https://doi.org/10.52547/rbmb.11.1.111

Published Online: 2022-04-01

Update policy: https://doi.org/10.29252/crossmark-policy

About CrossMark